CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Čes. Gynek. 72, 2007, č. 3 s. 200-202
 
The Use of Recombinant Factor VIIa on the Therapy of Massive Bleeding after Cesarean Section 
Uharček P, Mlynček M., Kellner M,. Lajtman E. 

Gynekologicko-pôrodnícka klinika, Fakultná nemocnica Nitra, prednosta kliniky doc. MUDr. M. Mlynček, CSc.
 


Summary:

       Objective: To present a case report of severe post-partum bleeding after caesarean section and successful treatment using recombinant factor VIIa. Setting: Obstetrics and Gynecology Department, Faculty Hospital, Nitra, Slovak Republic. Case report: A 29-year old secundigravida presented with major post-partum bleeding after caesarean section due to uterine atony. The patient developed hemorrhagic shock, associated with disseminated intravascular coagulation (DIC). Treatment with uterotonic drugs, prostaglandins and hysterectomy failed to control diffuse bleeding. Recombinant factor VIIa (90 μg/kg intravenous injection) was given as a final attempt to control the bleeding. The response to treatment was rapid, with control of the bleeding and resolution of the coagulopathy. Conclusion: This case suggests a potential role of recombination factor VIIa in the treatment of severe post-partum bleeding associated with DIC.

        Key words: recombinant FVIIa; bleeding; postpartum period
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER